Vanguard Personalized Indexing Management
VKTX icon

Vanguard Personalized Indexing Management’s Viking Therapeutics VKTX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
15,564
+1,519
+11% +$49.1K 0.01% 1292
2026
Q1 		$457K Sell
14,045
-174
-1% -$5.59K ﹤0.01% 1357
2025
Q4 		$500K Buy
14,219
+705
+5% +$25K ﹤0.01% 1247
2025
Q3 		$355K Sell
13,514
-1,093
-7% -$32.6K ﹤0.01% 1408
2025
Q2 		$387K Buy
14,607
+3,779
+35% +$99.5K ﹤0.01% 1321
2025
Q1 		$261K Buy
+10,828
New +$342K ﹤0.01% 1404
2024
Q4 		– Sell
-3,736
Closed -$237K – 1875
2024
Q3 		$237K Buy
+3,736
New +$219K ﹤0.01% 1461

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Personalized Indexing Management's VKTX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Viking Therapeutics (VKTX) stake by 11% in Q2 2026, buying an estimated $49.1K and bringing the position to 15,564 shares worth $607K. The position accounts for 0.01% of the portfolio, ranked #1292.

Vanguard Personalized Indexing Management first reported a position in VKTX in Q3 2024 and has held it in 7 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 15,564 shares of Viking Therapeutics worth $607K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 1,519 Viking Therapeutics shares in Q2 2026, an estimated $49.1K.
  • Viking Therapeutics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1292 holding.
  • Vanguard Personalized Indexing Management first reported a position in Viking Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.